乌龟刻苦
发表于 2025-2-25 08:55:47
首批！义乌成功入选！
<!----><style type="text/css">html{font-size:375%}</style><link href="https://pics-app.cnyw.net/static/publish/css/style.css?v=20240712" rel="stylesheet" position="1" data-qf-origin="/static/publish/css/style.css?v=20240712"><!-- 付费贴--> <div class="preview_article "> <!----> <p style="text-align: center; margin-bottom: 0px;"> </p><section><section><section><section><section><section><section><section><section><section style="margin: 10px auto; background-color: #eefcfc; overflow: hidden; border: 1px solid #51d1cc;"><section style="padding-top: 15px; padding-right: 15px; padding-left: 15px; transform: rotateZ(0deg);"><section style="line-height: 1.75em; letter-spacing: 1.5px; font-size: 18px; color: #333333; background-color: transparent;"><p style="line-height: 1.75em; text-indent: 2em;"><span style="font-size: 16px; background-color: transparent;">近日，浙江省正式发文公布首批“小而强”临床创新团队入选名单，启动建设省级“小而强”临床创新团队（含培育创新团队）92个，并在全省新开设以团队名称命名的专病门诊。</span><span style="font-size: 16px; background-color: transparent;">其中，义乌2个创新团队入选。</span></p></section></section><section style="margin-top: -29px; margin-right: -10px; margin-left: auto; width: 60px; opacity: 0.8;"><img class="rich_pages wxw-img" style="display: block; vertical-align: baseline; width: 100%;" src="https://pics-app.cnyw.net/FmgzO5E9rHK8hWPHkcUGxTworZGT" /></section></section></section><section><section><p> </p></section><section style="text-align: center; line-height: 1.75em;"><span style="font-size: 16px;"><strong>首批省级“小而强”临床创新团队入选名单</strong></span><strong style="font-size: 16px; caret-color: red;"><img class="rich_pages wxw-img" style="vertical-align: middle; width: 100%; height: auto;" src="https://pics-app.cnyw.net/FnuESsknjM9E8I_T3v03d7R2zyqe" alt="11.png" /></strong></section><p> </p></section><section><section><section style="margin: 10px auto; background-color: #eefcfc; padding: 13px;"><section style="display: flex; justify-content: flex-start; align-items: center;"><section style="flex-shrink: 0;"><section style="width: 30px;"><img style="width: 100%; display: block; opacity: 0.9; vertical-align: baseline;" src="https://pics-app.cnyw.net/FgCR01RtpfSoED0e3ey3t4K0Y4c8" /></section></section><section style="display: flex; align-items: flex-end;"><section style="flex-shrink: 0; padding-bottom: 3px;"><section style="width: 15px;"></section></section><section style="font-size: 16px; color: #ffffff; padding: 4px 15px; background-color: #51d1cc; border-radius: 25px; margin-left: -10px;"><p><strong>免疫耐受性肺鳞癌“小而强”临床创新团队</strong></p></section></section></section><section style="line-height: 1.75em; letter-spacing: 1.5px; font-size: 16px; color: #333333; background-color: transparent; padding-top: 7px;"><p style="text-indent: 2.1875em;"><span style="color: #31859b;"><strong><span style="caret-color: #ff0000; font-family: mp-quote, -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;">免疫耐受性肺鳞癌“小而强”临床创新团队</span></strong></span><span style="caret-color: #ff0000; font-family: mp-quote, -apple-system-font, BlinkMacSystemFont, Arial, sans-serif;">，对肺癌免疫耐药机制等关键临床难题进行科技攻关，探索免疫治疗新策略，通过多种途径增强免疫系统的抗肿瘤反应，聚焦免疫耐受性肺鳞癌等“卡脖子”问题开展研究。</span></p></section></section></section><section><section style="margin: 10px auto; background-color: #eefcfc; padding: 13px;"><section style="display: flex; justify-content: flex-start; align-items: center;"><section style="flex-shrink: 0;"><section style="width: 30px;"><img style="width: 100%; display: block; opacity: 0.9; vertical-align: baseline;" src="https://pics-app.cnyw.net/FgCR01RtpfSoED0e3ey3t4K0Y4c8" /></section></section><section style="display: flex; align-items: flex-end;"><section style="flex-shrink: 0; padding-bottom: 3px;"><section style="width: 15px;"></section></section><section style="font-size: 16px; color: #ffffff; padding: 4px 15px; background-color: #51d1cc; border-radius: 25px; margin-left: -10px;"><p><strong>结直肠癌肝转移“小而强”临床创新团队</strong></p></section></section></section><section style="line-height: 1.75em; letter-spacing: 1.5px; font-size: 14px; color: #333333; background-color: transparent; padding-top: 7px;"><p style="max-inline-size: 100%; cursor: text; text-indent: 2.1875em; font-size: 16px;"><span style="color: #31859b;"><strong>结直肠癌肝转移“小而强”临床创新团队</strong></span><span style="max-inline-size: 100%; cursor: text;">，致力于提高结直肠癌肝转移诊疗水平、系统性解决目前诊疗方案争议，为完善全国结直肠癌肝转移规范化诊疗指南提供“浙江经验”。</span></p></section></section></section><p style="text-indent: 2em;"> </p><p style="text-indent: 2em; font-size: 16px;">“小而强”临床创新团队主要面向浙江省重点需要解决的多发、高发、疑难疾病，组建优势人才团队，开设专病门诊，协同技术攻关，提高疾病诊疗效果，打造临床特色品牌，推动医院特色化、差异化发展，更好满足群众看病就医需求，让优质人才资源、医疗资源、创新成果惠及更多群众。</p><p class="empty_paragraph" style="text-indent: 2em; font-size: 16px;"> </p></section></section></section></section></section></section></section></section></section><section><section><section><section><section><section><section><section style="outline: 0px; font-size: 16px; vertical-align: initial; visibility: visible;"><section style="outline: 0px; vertical-align: initial; visibility: visible;"><section style="outline: 0px; vertical-align: initial; visibility: visible;"><section style="color: #333333; letter-spacing: 0.544px; outline: 0px; font-family: system-ui, -apple-system, BlinkMacSystemFont, Arial, sans-serif;"><section style="margin-bottom: 10px; outline: 0px; letter-spacing: 0.578px; caret-color: rgba(0, 0, 0, 0); text-align: left; widows: 1; vertical-align: initial; visibility: visible;"><section style="outline: 0px; letter-spacing: 0.544px; text-align: justify; color: #222222; visibility: visible;"><section style="outline: 0px; color: #333333;"><section style="margin: 10px auto; outline: 0px; display: flex; justify-content: space-between; align-items: flex-end;"><section style="outline: 0px; display: flex; justify-content: center; align-items: flex-end;"><section style="margin-left: 10px; outline: 0px; width: auto;"><section style="outline: 0px; text-align: center; font-size: 14px; letter-spacing: 1.5px; color: #000000;"></section></section></section></section></section></section></section></section></section></section></section></section><section style="color: #333333; font-family: system-ui, -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; letter-spacing: 0.544px; outline: 0px;"><section style="outline: 0px;"><section style="margin-bottom: 10px; outline: 0px; letter-spacing: 0.578px; caret-color: rgba(0, 0, 0, 0); text-align: left; widows: 1; vertical-align: inherit; visibility: visible; font-family: system-ui, -apple-system, BlinkMacSystemFont, Arial, sans-serif;"><section style="outline: 0px;"><section style="outline: 0px; letter-spacing: 0.544px; text-align: justify; color: #222222; visibility: visible;"><section style="outline: 0px; color: #333333;"><section style="margin: 10px auto; outline: 0px; display: flex; justify-content: space-between; align-items: flex-end;"><section style="outline: 0px; display: flex; justify-content: center; align-items: flex-end;"><section style="margin-left: 10px; outline: 0px; width: auto;"><section style="outline: 0px; text-align: center; font-size: 14px; letter-spacing: 1.5px; color: #000000;"></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p style="display: none;"> </p> <!----></div>
张红旗
发表于 2025-2-25 09:25:45
標題黨鑒定完畢
dogpile
发表于 2025-2-25 10:31:37
换个身份回来
微之路
发表于 2025-2-25 12:17:51
路过
任老师
发表于 2025-2-25 12:17:55
可以
萧岩山人
发表于 2025-2-25 12:35:32
好好
sgj
发表于 2025-2-25 12:35:34
啊啊啊啊啊
吴建杰
发表于 2025-2-25 12:39:55
看看
相丛
发表于 2025-2-25 13:14:13
创新创标题
稠城二哥
发表于 2025-2-25 13:47:35
好好好
页:
[1]
2
3
4
5
6
7
8
9
10